Erelzi 25Mg. 50Mg 25mg. 50mg Solution for injection
PDF Leaflet Revision Date: 24 July 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of various autoimmune conditions including rheumatoid arthritis and plaque psoriasis.
Dosage (summary)
Adults: 25 mg twice weekly or 50 mg once weekly. Children: 0.4 mg/kg (max 25 mg) twice weekly or 0.8 mg/kg (max 50 mg) once weekly.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Use only if clearly needed; crosses placenta and excreted in breast milk.
Key Drug Interactions
- Anakinra
- Abatacept
- Sulfasalazine
Contraindications
- Hypersensitivity to etanercept
- Active infections
- Sepsis
Common side effects
- Injection site reactions
- Infections
- Headache
- Allergic reactions
Counselling Points
- Monitor for signs of infection
- Avoid live vaccines
- Report any allergic reactions
Serious warnings
- Serious infections including tuberculosis
- Malignancies
- Autoimmune disorders
On This Page
Loading package insert…
Medinsert AI
Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
